Table of Contents Global Neurotherapeutic Drugs Market Research Report 2017 1 Neurotherapeutic Drugs Market Overview 1.1 Product Overview and Scope of Neurotherapeutic Drugs 1.2 Neurotherapeutic Drugs Segment by Type (Product Category) 1.2.1 Global Neurotherapeutic Drugs Production and CAGR (%) Comparison by Type (Product Category)(2012-2022) 1.2.2 Global Neurotherapeutic Drugs Production Market Share by Type (Product Category) in 2016 1.2.3 Peripheral Nervous System Disorders (PNS) Disorder 1.2.4 Autonomous Nervous System (ANS) Disorder 1.2.5 Central Nervous System (CNS) Disorders 1.2.6 Other 1.3 Global Neurotherapeutic Drugs Segment by Application 1.3.1 Neurotherapeutic Drugs Consumption (Sales) Comparison by Application (2012-2022) 1.3.2 Hosptical 1.3.3 Drug Stores 1.3.4 Other 1.4 Global Neurotherapeutic Drugs Market by Region (2012-2022) 1.4.1 Global Neurotherapeutic Drugs Market Size (Value) and CAGR (%) Comparison by Region (2012-2022) 1.4.2 North America Status and Prospect (2012-2022) 1.4.3 Europe Status and Prospect (2012-2022) 1.4.4 China Status and Prospect (2012-2022) 1.4.5 Japan Status and Prospect (2012-2022) 1.4.6 Southeast Asia Status and Prospect (2012-2022) 1.4.7 India Status and Prospect (2012-2022) 1.5 Global Market Size (Value) of Neurotherapeutic Drugs (2012-2022) 1.5.1 Global Neurotherapeutic Drugs Revenue Status and Outlook (2012-2022) 1.5.2 Global Neurotherapeutic Drugs Capacity, Production Status and Outlook (2012-2022) 2 Global Neurotherapeutic Drugs Market Competition by Manufacturers 2.1 Global Neurotherapeutic Drugs Capacity, Production and Share by Manufacturers (2012-2017) 2.1.1 Global Neurotherapeutic Drugs Capacity and Share by Manufacturers (2012-2017) 2.1.2 Global Neurotherapeutic Drugs Production and Share by Manufacturers (2012-2017) 2.2 Global Neurotherapeutic Drugs Revenue and Share by Manufacturers (2012-2017) 2.3 Global Neurotherapeutic Drugs Average Price by Manufacturers (2012-2017) 2.4 Manufacturers Neurotherapeutic Drugs Manufacturing Base Distribution, Sales Area and Product Type 2.5 Neurotherapeutic Drugs Market Competitive Situation and Trends 2.5.1 Neurotherapeutic Drugs Market Concentration Rate 2.5.2 Neurotherapeutic Drugs Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Neurotherapeutic Drugs Capacity, Production, Revenue (Value) by Region (2012-2017) 3.1 Global Neurotherapeutic Drugs Capacity and Market Share by Region (2012-2017) 3.2 Global Neurotherapeutic Drugs Production and Market Share by Region (2012-2017) 3.3 Global Neurotherapeutic Drugs Revenue (Value) and Market Share by Region (2012-2017) 3.4 Global Neurotherapeutic Drugs Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

List of Tables and Figures Figure Picture of Neurotherapeutic Drugs Figure Global Neurotherapeutic Drugs Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022) Figure Global Neurotherapeutic Drugs Production Market Share by Types (Product Category) in 2016 Figure Product Picture of Peripheral Nervous System Disorders (PNS) Disorder Table Major Manufacturers of Peripheral Nervous System Disorders (PNS) Disorder Figure Product Picture of Autonomous Nervous System (ANS) Disorder Table Major Manufacturers of Autonomous Nervous System (ANS) Disorder Figure Product Picture of Central Nervous System (CNS) Disorders Table Major Manufacturers of Central Nervous System (CNS) Disorders Figure Product Picture of Other Table Major Manufacturers of Other Figure Global Neurotherapeutic Drugs Consumption (K Units) by Applications (2012-2022) Figure Global Neurotherapeutic Drugs Consumption Market Share by Applications in 2016 Figure Hosptical Examples Table Key Downstream Customer in Hosptical Figure Drug Stores Examples Table Key Downstream Customer in Drug Stores Figure Other Examples Table Key Downstream Customer in Other Figure Global Neurotherapeutic Drugs Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022) Figure North America Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2022) Figure Europe Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2022) Figure China Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2022) Figure Japan Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2022) Figure Southeast Asia Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2022) Figure India Neurotherapeutic Drugs Revenue (Million USD) and Growth Rate (2012-2022) Figure Global Neurotherapeutic Drugs Revenue (Million USD) Status and Outlook (2012-2022) Figure Global Neurotherapeutic Drugs Capacity, Production (K Units) Status and Outlook (2012-2022) Figure Global Neurotherapeutic Drugs Major Players Product Capacity (K Units) (2012-2017) Table Global Neurotherapeutic Drugs Capacity (K Units) of Key Manufacturers (2012-2017) Table Global Neurotherapeutic Drugs Capacity Market Share of Key Manufacturers (2012-2017) Figure Global Neurotherapeutic Drugs Capacity (K Units) of Key Manufacturers in 2016 Figure Global Neurotherapeutic Drugs Capacity (K Units) of Key Manufacturers in 2017 Figure Global Neurotherapeutic Drugs Major Players Product Production (K Units) (2012-2017) Table Global Neurotherapeutic Drugs Production (K Units) of Key Manufacturers (2012-2017) Table Global Neurotherapeutic Drugs Production Share by Manufacturers (2012-2017) Figure 2016 Neurotherapeutic Drugs Production Share by Manufacturers Figure 2017 Neurotherapeutic Drugs Production Share by Manufacturers F